药物组合的知识意识协同发现:一个大语言模型视角
IEEE transactions on computational biology and bioinformatics
|August 14, 2025
概括
这项研究介绍了KSDDC,一种使用大型语言模型 (LLM) 预测用于癌症治疗的协同药物组合的新型模型. KSDDC集成了专业知识,在药物协同发现方面表现优于现有方法.
科学领域:
- 在瘤学瘤学.
- 计算生物学 计算生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 药物组合疗法是癌症治疗的基石,提供协同效应的优势.
- 目前用于药物协同效应预测的深度学习方法经常忽视特定领域的数据特征和知识整合.
- 有效地将分散的专业知识纳入数据挖掘仍然是一个重大挑战.
研究的目的:
- 提出KSDDC,一种用于协同药物组合发现的新型知识意识模型.
- 通过整合系统知识,利用大型语言模型 (LLM) 进行增强的药物协同预测.
- 提高在癌症治疗中预测有效药物组合的准确性和可靠性.
主要方法:
- 开发了KSDDC,该模型利用大语言模型 (LLM) 视角进行知识集成.
- 实施了三个核心模块:知识意识药物特征自动编码,知识意识细胞系特征编码和药物药物协同作用预测.
- 通过结合样本特征来准确预测协同效应,生成信息嵌入.
主要成果:
- 与浅层和深层机器学习方法相比,KSDDC在协同预测基准上表现优越.
- 在DrugComb_1数据集上,与第二最佳方法相比,F1得分大约有19%的改善.
- 在药物协同发现中验证了基于知识的数据挖掘在药物协同发现中的有效性.
结论:
- KSDDC为知识意识的协同药物发现提供了一种新且有效的方法.
- 该模型集成专业知识的能力提高了药物协同效应预测的准确性.
- 这项研究提供了有价值的见解和参考方法,用于未来的癌症药物组合疗法研究.
相关概念视频
Drug Discovery: Overview
8.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.7K
Combined Effects of Drugs: Synergism
4.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.7K
Pharmacokinetic Models: Overview
1.1K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.1K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
126
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
126
Agonism and Antagonism: Quantification
566
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
566
Combined Effects of Drugs: Antagonism
9.3K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
9.3K


